Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081886 | SCV000113821 | benign | not specified | 2013-03-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000081886 | SCV000316191 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Pediatric Genomic Medicine, |
RCV000417740 | SCV000510907 | likely benign | not provided | 2016-11-30 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001083808 | SCV000630865 | benign | Cohen syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000417740 | SCV000841629 | likely benign | not provided | 2017-09-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311679 | SCV000846210 | benign | Inborn genetic diseases | 2017-04-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV001083808 | SCV001325571 | benign | Cohen syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000417740 | SCV001889822 | benign | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16648375, 19006247) |
Ce |
RCV000417740 | SCV004032822 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | VPS13B: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000417740 | SCV005223945 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000081886 | SCV000153486 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Laboratory of Diagnostic Genome Analysis, |
RCV000417740 | SCV001798975 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000081886 | SCV001952257 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000417740 | SCV001970095 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome |
RCV000417740 | SCV002074826 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. | |
Natera, |
RCV001083808 | SCV002079514 | benign | Cohen syndrome | 2019-12-06 | no assertion criteria provided | clinical testing |